Frontage offers an impressive suite of services to take lead candidate drugs to the IND stage. With Experimur’s acquisition, Frontage now has significantly expanded our range of services, supporting customers’ drug-development programs beyond IND and into NDA-enabling toxicology studies. Frontage has exceptional bioanalytical supporting capabilities for small molecules, large molecules, and biomarkers.
Register to gain access to gated resources.
Thank you for registering!
You now have the option of downloading the resource or viewing the web version below.
At Frontage, we simplify the effort of Investigational New Drug (IND) and reduce the risk by offering all of the critical IND-enabling services required to bring your lead candidate to Phase 1. By providing the right comprehensive end-to-end services, we can accelerate your IND program with the benefit of consistent quality, enhanced efficiency, and optimal cross-functional communications.
Frontage Laboratories, Inc. is a full-service CRO providing integrated, scientifically-driven research, analytical and development services. With over 20 years of experience, we have successfully assisted our clients in advancing hundreds of compounds through the drug development process.